Integra LifeSciences (IART) vs Kestra Medical Technologies (KMTS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
Kestra Medical Technologies (KMTS) has outperformed Integra LifeSciences (IART) over the past year, gaining 14.9% versus a loss of 5.1%. Kestra Medical Technologies is the larger company by market cap ($1.61 billion vs $1.05 billion), about 1.5 times the size. Integra LifeSciences converts more of its revenue into profit, with a net margin of -31.6% versus -138.4%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | IART | KMTS |
|---|---|---|
| Share price | $13.44 | $26.98 |
| Market cap | $1.05B | $1.61B |
| 1-day change | +0.22% | +4.70% |
| YTD return | +8.21% | +1.73% |
| 1-year return | -5.08% | +14.86% |
| 5-year return | -80.14% | — |
| Forward P/E | 5.17 | — |
| EPS (TTM) | $-0.09 | $-2.67 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $1.64B | $95.13M |
| Revenue growth (YoY) | +1.53% | +59.03% |
| Net income (latest FY) | $-516.47M | $-131.61M |
| Gross margin | 50.86% | 51.37% |
| Operating margin | -30.17% | -141.64% |
| Net margin | -31.58% | -138.36% |
| 52-week high | $20.49 | $30.00 |
| 52-week low | $8.70 | $17.34 |
| Distance from 52-week high | -34.41% | -10.07% |
| Analyst consensus | hold | strong_buy |
| Avg. price target upside | +36.76% | +12.27% |
| Average volume | 920.87K | 354.62K |
| Shares outstanding | 77.77M | 59.56M |
| Employees | 4,427 | 443 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- KMTS has outperformed IART by 19.9 percentage points over the past year.
- Integra LifeSciences is more profitable, keeping -31.6 cents of every revenue dollar as net income versus -138.4 cents for Kestra Medical Technologies.
- Kestra Medical Technologies grew revenue faster in its latest fiscal year (+59.03% vs +1.53%).
About Integra LifeSciences
IART stock →Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates through Codman Specialty Surgical and Tissue Technologies segments.
Health Care · Medical/Dental Instruments · 4,427 employees
About Kestra Medical Technologies
KMTS stock →Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company.
Health Care · Medical/Dental Instruments · 443 employees
IART vs KMTS FAQ
Which is bigger, Integra LifeSciences or Kestra Medical Technologies?
Kestra Medical Technologies (KMTS) is larger, with a market capitalization of $1.61B compared with $1.05B for Integra LifeSciences (IART).
Which stock has performed better over the past year, IART or KMTS?
KMTS returned +14.86% over the past 12 months, compared with -5.08% for IART (price return, excluding dividends). Past performance does not predict future results.
Are Integra LifeSciences and Kestra Medical Technologies in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.